The company informs that it has secured the attendance or proxy delegation of over 50% of its share capital, which guarantees the holding of the General Extraordinary Shareholders’ Meeting on first call, this is, on Friday, October 24, 2014 at 12.00 am, at Valencia Stock Exchange, Libreros, 2-4 (Valencia, Spain)
The board of directors of both companies approved the pro forma combined financial statements for the period of nine months ended on June 30, 2014. This information intends solely to facilitate greater understanding of the company resulting from the potential merger
Natraceutical and Laboratorio Reig Jofre join the consolidation process of the European pharmaceutical industry
The new company resulting from the merger will strengthen its position in the pharmaceutical market by means of the synergies in research and development of new products, regulatory knowledge, own production and combined access to more than 60 countries in 5 continents
After obtaining a favorable report on the exchange ratio by the independent expert and the close of the file on the economic concentration of the merger by the Spanish Commission of Markets and Competition, the comopany announces public presentations on the merger project to take place in the coming weeks.